These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 28117405)
1. Biological Membrane-Packed Mesenchymal Stem Cells Treat Acute Kidney Disease by Ameliorating Mitochondrial-Related Apoptosis. Geng X; Hong Q; Wang W; Zheng W; Li O; Cai G; Chen X; Wu D Sci Rep; 2017 Jan; 7():41136. PubMed ID: 28117405 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis. Qi S; Wu D Int J Mol Med; 2013 Dec; 32(6):1262-72. PubMed ID: 24126885 [TBL] [Abstract][Full Text] [Related]
3. Rhabdomyolysis-Induced AKI Was Ameliorated in NLRP3 KO Mice via Alleviation of Mitochondrial Lipid Peroxidation in Renal Tubular Cells. Song SJ; Kim SM; Lee SH; Moon JY; Hwang HS; Kim JS; Park SH; Jeong KH; Kim YG Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202867 [TBL] [Abstract][Full Text] [Related]
4. Gallic Acid Improves Therapeutic Effects of Mesenchymal Stem Cells Derived from Adipose Tissue in Acute Renal Injury Following Rhabdomyolysis Induced by Glycerol. Mard SA; Hoseinynejad K; Nejaddehbashi F Inflammation; 2022 Dec; 45(6):2294-2308. PubMed ID: 35789305 [TBL] [Abstract][Full Text] [Related]
5. Amelioration of rhabdomyolysis-induced renal mitochondrial injury and apoptosis through suppression of Drp-1 translocation. Tang WX; Wu WH; Qiu HY; Bo H; Huang SM J Nephrol; 2013; 26(6):1073-82. PubMed ID: 23553524 [TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages. Geng Y; Zhang L; Fu B; Zhang J; Hong Q; Hu J; Li D; Luo C; Cui S; Zhu F; Chen X Stem Cell Res Ther; 2014 Jun; 5(3):80. PubMed ID: 24961539 [TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid pretreatment of mesenchymal stem cells enhances the therapeutic effect on acute kidney injury. Zhang Y; Wang X; Ji Y; Hong H; Geng X; Zhang K; Fu Z; Cai G; Chen X; Li P; Hong Q Cell Commun Signal; 2024 May; 22(1):291. PubMed ID: 38802835 [TBL] [Abstract][Full Text] [Related]
8. Gene Microarray Integrated with High-Throughput Proteomics for the Discovery of Transthyretin in Rhabdomyolysis-Induced Acute Kidney Injury. Li O; Geng X; Ma Q; Wang W; Liu R; Yin Z; Wang S; Cai G; Chen X; Hong Q Cell Physiol Biochem; 2017; 43(4):1673-1688. PubMed ID: 29040977 [TBL] [Abstract][Full Text] [Related]
10. Adipose-derived mesenchymal stem cells cultured in serum-free medium attenuate acute contrast-induced nephropathy by exerting anti-apoptotic effects. Kadono M; Nakashima A; Ishiuchi N; Sasaki K; Miura Y; Maeda S; Fujita A; Sasaki A; Nagamatsu S; Masaki T Stem Cell Res Ther; 2023 Nov; 14(1):337. PubMed ID: 37993965 [TBL] [Abstract][Full Text] [Related]
11. Curcumin-Loaded Nanoparticles Protect Against Rhabdomyolysis-Induced Acute Kidney Injury. Chen X; Sun J; Li H; Wang H; Lin Y; Hu Y; Zheng D Cell Physiol Biochem; 2017; 43(5):2143-2154. PubMed ID: 29065403 [TBL] [Abstract][Full Text] [Related]
12. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats. Kim JH; Park DJ; Yun JC; Jung MH; Yeo HD; Kim HJ; Kim DW; Yang JI; Lee GW; Jeong SH; Roh GS; Chang SH Am J Physiol Renal Physiol; 2012 May; 302(9):F1141-50. PubMed ID: 22205231 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cells: a Promising Therapeutic Tool for Acute Kidney Injury. Selim RE; Ahmed HH; Abd-Allah SH; Sabry GM; Hassan RE; Khalil WKB; Abouhashem NS Appl Biochem Biotechnol; 2019 Sep; 189(1):284-304. PubMed ID: 30976980 [TBL] [Abstract][Full Text] [Related]
14. Paracrine Activation of the Wnt/β-Catenin Pathway by Bone Marrow Stem Cell Attenuates Cisplatin-Induced Kidney Injury. Jiao X; Cai J; Yu X; Ding X Cell Physiol Biochem; 2017; 44(5):1980-1994. PubMed ID: 29237155 [TBL] [Abstract][Full Text] [Related]
15. Transplantation of bone marrow-derived MSCs improves cisplatinum-induced renal injury through paracrine mechanisms. Cheng K; Rai P; Plagov A; Lan X; Kumar D; Salhan D; Rehman S; Malhotra A; Bhargava K; Palestro CJ; Gupta S; Singhal PC Exp Mol Pathol; 2013 Jun; 94(3):466-73. PubMed ID: 23534987 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells ameliorate cisplatin-induced acute kidney injury via let-7b-5p. Wang SY; Xu Y; Hong Q; Chen XM; Cai GY Cell Tissue Res; 2023 May; 392(2):517-533. PubMed ID: 36543894 [TBL] [Abstract][Full Text] [Related]
17. Differences in gene expression profiles and signaling pathways in rhabdomyolysis-induced acute kidney injury. Geng X; Wang Y; Hong Q; Yang J; Zheng W; Zhang G; Cai G; Chen X; Wu D Int J Clin Exp Pathol; 2015; 8(11):14087-98. PubMed ID: 26823722 [TBL] [Abstract][Full Text] [Related]
18. A dual role of miR-22 in rhabdomyolysis-induced acute kidney injury. Mathia S; Rudigier LJ; Kasim M; Kirschner KM; Persson PB; Eckardt KU; Rosenberger C; Fähling M Acta Physiol (Oxf); 2018 Nov; 224(3):e13102. PubMed ID: 29791781 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury. Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874 [TBL] [Abstract][Full Text] [Related]